SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000899140-07-000527
Filing Date
2007-03-05
Accepted
2007-03-05 10:53:31
Documents
4
Group Members
DANIEL S. LOEB

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING t030507b.txt SC 13D 29790
3 t030507c.txt EX-99.1 8790
4 JOINT FILING AGREEMENT t030507d.txt EX-99.2 2237
5 POA t030507e.txt EX-99.3 4804
  Complete submission text file 0000899140-07-000527.txt   47832
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-43256 | Film No.: 07669952
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

IRS No.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D